← All stories
Markets
GSK (LSE:GSK) Stock in Focus as Drug Pipeline Advances
Highlights Jemperli gains priority regulatory review in the United States. Hibsago receives an important regulatory clearance in Japan. GSK advances treatments across oncology and liver disease. GSK is progressing across two important thera…
Covered by 1 outlet
All coverage · 1 article